Finance

Beta
Lists
300942:SHE
Shenzhen Bioeasy Biotechnology Co Ltd
CN¥6.22
-2.35%
(-0.15) 1D
Jun 10, 3:04:13 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300942...
Open
CN¥6.30
High
CN¥6.35
Low
CN¥6.11
Mkt. cap
2.58B
Avg. vol.
6.01M
Volume
5.01M
Dividend
0.40%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
358.50
52-wk high
CN¥14.15
52-wk low
CN¥6.11
EPS
CN¥0.02
Shares outstanding
405.08M
No. of employees
542
Open
CN¥6.30
High
CN¥6.35
Low
CN¥6.11
Mkt. cap
2.58B
Avg. vol.
6.01M
Volume
5.01M
Dividend
0.40%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
358.50
52-wk high
CN¥14.15
52-wk low
CN¥6.11
EPS
CN¥0.02
Shares outstanding
405.08M
No. of employees
542
News stories
From sources across the web
About Shenzhen Bioeasy Biotechnology Co Ltd
CEO-
Employees542
FoundedJul 24, 2007
Headquarters-
SectorMedical device
Websitebioeasy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
59.94M
76.35M
77.60M
57.64M
Cost of goods sold
15.54M
27.22M
30.92M
25.48M
Cost of revenue
15.54M
27.22M
30.92M
25.48M
Research and development expenses
11.36M
11.22M
10.63M
9.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.58M
26.87M
29.32M
26.77M
Operating expense
39.34M
38.32M
43.88M
36.28M
Total operating expenses
54.88M
65.54M
74.81M
61.76M
Operating income
5.06M
10.81M
2.79M
-4.12M
Other non operating income
-1.11M
3.24M
-3.36M
-6.14M
EBT including unusual items
5.68M
16.34M
-3.70M
-13.09M
EBT excluding unusual items
4.08M
4.75M
-6.22M
-15.51M
Income tax expense
-443.19K
-574.58K
-358.78K
-2.60M
Effective tax rate
-7.80%
-3.52%
9.70%
19.90%
Other operating expenses
-645.39K
26.32K
-109.59K
-898.93K
Net income
5.69M
15.68M
-4.28M
-10.26M
Net profit margin
9.48%
20.54%
-5.52%
-17.80%
Earnings per share
-
-
-
-
Interest and investment income
2.06M
2.03M
2.22M
1.46M
Interest expense
-6.35M
-6.91M
-6.82M
-6.72M
Net interest expenses
-4.29M
-4.88M
-4.59M
-5.25M
Depreciation and amortization charges
-
-
-
-
EBITDA
10.89M
14.14M
10.19M
3.28M
Gain or loss from assets sale
-171.59K
171.59K
-12.21M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer